Table 1.

Patients’ characteristics.

Clinical factor (n = 82)	Median (range) or n (%)
Age (y)	66 (50–75)
cT stage (n)
1	54 (69.23%)
2	13 (16.67%)
3	11 (14.10%)
GS (n)
6	24 (29.27%)
7	37 (45.12%)
8	12 (14.63%)
9	9 (10.98%)
TST (ng/dL)	4.64 (0.42–10.9)
PSA (ng/mL)	7.87 (2.45–31.78)
PSAD	0.30 (0.06–1.44)

cT stage = clinical tumour stage, GS = Gleason score, TST = testosterone, PSA = prostate-specific antigen, PSAD = PSA density.